(Q37082055)

18 August 2017

1 reference

title

Gene-environment interactions in Parkinson's disease (English)

1 reference

18 August 2017

1 reference

1

Christopher A Ross

1 reference

18 August 2017

Wanli W Smith

2

1 reference

18 August 2017

1 January 2007

1 reference

Parkinsonism and Related Disorders

18 August 2017

1 reference

18 August 2017

13 Suppl 3

1 reference

18 August 2017

S309-15

1 reference

Genetics of Parkinson's disease and parkinsonism

18 August 2017

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2808%2970022-1

7 January 2021

Deciphering the role of heterozygous mutations in genes associated with parkinsonism

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2808%2970022-1

7 January 2021

Parkinson's disease and pesticide exposures

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2808%2970022-1

7 January 2021

Pesticide exposure and risk for Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2808%2970022-1

7 January 2021

Endoplasmic reticulum stress and mitochondrial cell death pathways mediate A53T mutant alpha-synuclein-induced toxicity

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2808%2970022-1

7 January 2021

Leucine-rich repeat kinase 2 (LRRK2) interacts with parkin, and mutant LRRK2 induces neuronal degeneration

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2808%2970022-1

7 January 2021

Kinase activity of mutant LRRK2 mediates neuronal toxicity

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2808%2970022-1

7 January 2021

The fly as a model for neurodegenerative diseases: is it worth the jump?

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2808%2970022-1

7 January 2021

Behavioral phenotypes and pharmacology in genetic mouse models of Parkinsonism

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2808%2970022-1

7 January 2021

Model fusion, the next phase in developing animal models for Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2808%2970022-1

7 January 2021

Leucine-rich repeat kinase 2 (LRRK2)/PARK8 possesses GTPase activity that is altered in familial Parkinson's disease R1441C/G mutants

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2808%2970022-1

7 January 2021

The familial Parkinsonism gene LRRK2 regulates neurite process morphology

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2808%2970022-1

7 January 2021

Parkinson's disease: a rethink of rodent models.

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2808%2970022-1

7 January 2021

Inducible expression of mutant alpha-synuclein decreases proteasome activity and increases sensitivity to mitochondria-dependent apoptosis

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2808%2970022-1

7 January 2021

Parkinson's disease genetic mutations increase cell susceptibility to stress: mutant alpha-synuclein enhances H2O2- and Sin-1-induced cell death.

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2808%2970022-1

7 January 2021

10.1016/S1353-8020(08)70022-1

Identifiers

DOI

1 reference

18 August 2017

1 reference

PubMed ID

18267256